JPMorgan Chase & Co. Reiterates Neutral Rating for Smith & Nephew (LON:SN)

Smith & Nephew (LON:SN)‘s stock had its “neutral” rating reiterated by research analysts at JPMorgan Chase & Co. in a note issued to investors on Thursday, Analyst Ratings Network reports. They currently have a GBX 1,379 ($18.72) target price on the stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 9.40% from the stock’s current price.

A number of other brokerages have also weighed in on SN. Barclays reissued an “overweight” rating and issued a GBX 1,760 ($23.89) price target on shares of Smith & Nephew in a report on Wednesday, November 10th. Shore Capital reissued a “hold” rating on shares of Smith & Nephew in a report on Thursday, November 4th. Finally, Berenberg Bank raised their price target on shares of Smith & Nephew from GBX 1,825 ($24.77) to GBX 1,840 ($24.98) and gave the company a “buy” rating in a report on Friday, December 17th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of GBX 1,696 ($23.02).

LON SN opened at GBX 1,260.50 ($17.11) on Thursday. The firm has a market cap of £11.09 billion and a price-to-earnings ratio of 27.28. The company has a 50 day moving average of GBX 1,274.75 and a 200-day moving average of GBX 1,351.89. The company has a current ratio of 2.10, a quick ratio of 1.27 and a debt-to-equity ratio of 66.89. Smith & Nephew has a 1-year low of GBX 1,197.50 ($16.25) and a 1-year high of GBX 1,681.50 ($22.82).

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.

See Also: dividend yield calculator

Analyst Recommendations for Smith & Nephew (LON:SN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.